A study by Goidescu et al. demonstrated that the serum angiotensin-converting enzyme 2 (ACE2) and apelin-13 activity are correlated with an unfavorable clinical evolution in patients with reduced ejection fraction HF [36]. This evidence concerns the gene ACE2 and hydrops fetalis.